Highly invasive human breast cancer cell lines (MDA-MB-231 and BT-549) were shown to express low levels of CCRL2, and overexpression of the receptor negatively affected the growth of these cells in vitro and in vivo, as well as their chemotactic response to CCL2 and invasive properties [18]. This evidence concerns the gene CCL2 and breast carcinoma.